RankAlpha logo
Back to Rankings

COAG

Hemab TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
COAG vs peer average
26/100
COAG vs. peer average (D vs. B)
Grade spread
A 4 · B 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NKTR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.48B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNKTRNektar Therapeutics
COAG
Hemab Therapeutics
NKTR
Nektar Therapeutics
Grade
D
B
Momentum
49
48
Value
46
41
Sentiment
-
78
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs NKTR

COAG / NKTR
Grade Position
Below peers
COAG vs. peer average (D vs. B)
26/100
Momentum
49
COAG
Value
46
COAG
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs COAG
1
NKTR
Nektar Therapeutics Common
B
80/100
-2
2
PHVS
Pharvaris NV Common
D
40/100
Even
3
BCRX
BioCryst Pharmaceuticals Inc Common
A
100/100
-3
4
BHC
Bausch Health Companies Inc Common
A
100/100
-3
5
KOD
Kodiak Sciences Inc Common
A
100/100
-3
NKTR is the first peer returned for this comparison set.